Showing 81 - 100 results of 614 for search '"South Korea"', query time: 0.06s Refine Results
  1. 81

    A new record of the genus Parabioxys (Hymenoptera, Braconidae, Aphidiinae) and a redescription of Bioxys japonicus from South Korea by Sangjin Kim, JuHyeong Sohn, Yerim Lee, Yeonghyeok Yu, Hyojoong Kim

    Published 2025-02-01
    “…Bioxys japonicus Starý & Schlinger, 1967 was recorded in South Korea in 1983, but this record should be considered doubtful. …”
    Get full text
    Article
  2. 82

    Autophagy activation in response to cigarette smoke: Exploring the disparity in laryngeal cancer incidence and outcomes between sexes in South Korea by Min Ji Kim, Jisu Hong, Hyo Won Chang, Yun-Hee Lee, Jun-Pyo Myong, Ah Ra Jung, Yoon Se Lee, Minsu Kwon

    Published 2025-02-01
    “…Methods: This study analyzed the National Health Insurance Service (NHIS) data of South Korea to explore sex differences in LC incidence and clinical outcomes. …”
    Get full text
    Article
  3. 83

    Projection in Future Drought Hazard of South Korea Based on RCP Climate Change Scenario 8.5 Using SPEI by Byung Sik Kim, In Gi Chang, Jang Hyun Sung, Hae Jin Han

    Published 2016-01-01
    “…Through this, it could be projected that the drought scale and frequency and the drought intensity will become severer over South Korea because of future climate change.…”
    Get full text
    Article
  4. 84
  5. 85
  6. 86

    Therapeutic Decision Making in Hepatocellular Carcinoma According to Age and Child–Pugh Class: A Nationwide Cohort Analysis in South Korea by Sunmin Park, Chai Hong Rim, Young Kul Jung, Won Sup Yoon

    Published 2021-01-01
    “…We sought to analyze the preferred treatment modality by age and liver function in South Korea. Methods. The Korean Liver Cancer Study Group randomly extracted the data of patients with hepatocellular carcinoma (HCC) enrolled in the Korean Central Cancer Registry from 2008 to 2014 from approximately 50 hospitals nationwide. …”
    Get full text
    Article
  7. 87
  8. 88

    Assessing Wildfire Risk in South Korea Under Climate Change Using the Maximum Entropy Model and Shared Socioeconomic Pathway Scenarios by Jukyeong Choi, Heemun Chae

    Published 2024-12-01
    “…This study analyzed the probability of wildfire occurrence in South Korea using the Maximum Entropy (MaxEnt) model and predicted future wildfire occurrence under shared socioeconomic pathway (SSP) climate change scenarios. …”
    Get full text
    Article
  9. 89
  10. 90

    Comparison of the efficacy and safety of bupropion versus aripiprazole augmentation in adults with treatment-resistant depression: a nationwide cohort study in South Korea by Dong Yun Lee, Rae Woong Park, Soo Min Jeon

    Published 2025-01-01
    “…Data were collected from a nationwide claims database in South Korea. Patients prescribed bupropion were matched 1:1 with those prescribed aripiprazole. …”
    Get full text
    Article
  11. 91
  12. 92
  13. 93
  14. 94
  15. 95
  16. 96
  17. 97
  18. 98

    Gastric cancer incidence, mortality and burden in adolescents and young adults: a time-trend analysis and comparison among China, South Korea, Japan and the USA by Jian Li, Yao Zhang, Si Lin Wu, Yi Fu, Ji Sheng Wang

    Published 2022-07-01
    “…GC ranks fifth, first, fourth and ninth in China, South Korea, Japan and the USA regarding burdens caused by cancer in adolescents and young adults. …”
    Get full text
    Article
  19. 99

    Trends in prescribing sodium‐glucose cotransporter 2 inhibitors for individuals with type 2 diabetes with and without cardiovascular‐renal disease in South Korea, 2015–2021 by Kyoung Hwa Ha, Soyoung Shin, EunJi Na, Dae Jung Kim

    Published 2025-02-01
    “…ABSTRACT Background This study evaluates shifts in oral glucose‐lowering drug prescription patterns and the adoption of sodium‐glucose cotransporter 2 inhibitors (SGLT2is) in South Korea. Methods A cross‐sectional and retrospective cohort analysis of the Korean National Health Insurance database (2015–2021) assessed the prescription patterns of oral glucose‐lowering drugs by therapy level, SGLT2i prescriptions by cardiovascular‐renal disease (CVRD) status, and the mean duration for SGLT2i therapy initiation and intensification. …”
    Get full text
    Article
  20. 100